Consensus Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Delayed London S.E. Other stock markets 04:40:00 2024-05-21 am EDT			5-day change	1st Jan Change
150 ^GBX	+2.39%		+9.89%	-17.81%

May. 20	Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study	MT
May. 20	Arecor Therapeutics hails positive profile for insulin AT278	AN

Evolution of the average Target Price on Arecor Therapeutics plc

Price target over the last 5 years

History of analyst recommendation changes

30ef5a1f84b8da7e.bxtKzz8B-egqZG2qIEUMfSWeZT-muV8Zu3QiblrSUYo.XS4FthJEjLISNwzzQT8hFmn2CgzLiRNV2hNbDyicAMJcaQCeCHaXh201VQ~774a9424f0a13b3615cd00169759d7ab

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.465 GBP

Average target price

5.037 GBP

Spread / Average Target

+243.80%

High Price Target

5.84 GBP

Spread / Highest target

+298.63%

Low Price Target

4.03 GBP

Spread / Lowest Target

+175.09%

Consensus detail

Consensus revision (last 18 months)

Ratings for Arecor Therapeutics plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar